Suppr超能文献

血小板蛋白酶对凝血因子V的激活作用。

Activation of coagulation factor V by a platelet protease.

作者信息

Kane W H, Mruk J S, Majerus P W

出版信息

J Clin Invest. 1982 Nov;70(5):1092-100. doi: 10.1172/jci110697.

Abstract

Factor V must be converted to Factor V(a) in order to bind to a high affinity platelet surface site and participate in prothrombin activation. Osterud et al. (10) presented data that suggested that human platelets contain an activated form of Factor V and a Factor V activator. We find that the Factor V released when platelets are disrupted by freezing and thawing or sonication is activated 3- to 10-fold by thrombin as determined by coagulation assay and is therefore stored as the relatively inactive procofactor rather than in the active form Factor V(a). We incubated purified Factor V, which had a specific activity of 140+/-30 U/mg, with Factor V-deficient frozen and thawed platelets (10(9) platelets/ml) obtained from a patient with Factor V deficiency. The specific activity of the Factor V increased to a maximum of 740+/-240 U/mg (mean+/-SD of three experiments). When this partially activated Factor V was incubated with thrombin its specific activity increased further to 1,440+/-280 U/mg, which is similar to the activity of Factor V activated with thrombin alone (1,540+/-60 U/mg). The platelet Factor V activator is not inhibited by dansyl arginine-4-ethylpiperidine amide, 93 muM, indicating that it is not thrombin. When thrombin-stimulated platelets, to which dansyl arginine-4-ethylpiperidine amide had been added to inhibit the further action of thrombin, were incubated with (125)-labeled Factor V, there was no detectable proteolysis of the Factor V molecule. Our failure to detect activation of Factor V under these conditions suggests that <4% of the platelet protease is released by thrombin. Subcellular fractionation of platelets indicates that the platelet protease that activates Factor V is in the soluble fraction. When Factor V(a) formed by the action of platelet protease is incubated with platelets, peptides with M(r) = 105,000, 87,000, and 78,000 bind to the platelet surface. All three radiolabeled peptides are displaced from platelets by unlabeled Factor V(a) formed by the action of thrombin. The stoichiometry of binding suggests that the 105,000-dalton peptide is associated with either an 87,000- or a 78,000-dalton peptide. The 78,000-dalton peptide binds with greater affinity and probably accounts for the bulk of the activity of Factor V(a) in coagulation assays. Whether or not the platelet protease serves to activate Factor V before thrombin formation during normal hemostasis remains to be determined.

摘要

因子V必须转化为因子V(a)才能与高亲和力的血小板表面位点结合并参与凝血酶原激活。奥斯特鲁德等人(10)提供的数据表明,人血小板含有活化形式的因子V和一种因子V激活剂。我们发现,通过凝血试验测定,当血小板经冻融或超声破碎释放出的因子V被凝血酶激活3至10倍,因此它是以相对无活性的前辅因子形式储存,而非活性形式的因子V(a)。我们将比活性为140±30 U/mg的纯化因子V与从一名因子V缺乏症患者获得的经冻融的因子V缺乏血小板(10⁹个血小板/ml)一起孵育。因子V的比活性最高增加到740±240 U/mg(三次实验的平均值±标准差)。当将这种部分活化的因子V与凝血酶一起孵育时,其比活性进一步增加到1440±280 U/mg,这与仅用凝血酶激活的因子V的活性(1540±60 U/mg)相似。血小板因子V激活剂不受93 μM丹磺酰精氨酸 - 4 - 乙基哌啶酰胺的抑制,这表明它不是凝血酶。当向添加了丹磺酰精氨酸 - 4 - 乙基哌啶酰胺以抑制凝血酶进一步作用的凝血酶刺激血小板中加入¹²⁵标记的因子V时,未检测到因子V分子的蛋白水解。我们在这些条件下未能检测到因子V的激活,这表明凝血酶释放的血小板蛋白酶不到4%。血小板的亚细胞分级分离表明,激活因子V的血小板蛋白酶存在于可溶部分。当由血小板蛋白酶作用形成的因子V(a)与血小板一起孵育时,分子量为105,000、87,000和78,000的肽会结合到血小板表面。所有这三种放射性标记的肽都可被凝血酶作用形成的未标记因子V(a)从血小板上置换下来。结合的化学计量关系表明,105,000道尔顿的肽与87,000道尔顿或78,000道尔顿的肽相关联。78,000道尔顿的肽结合亲和力更高,可能在凝血试验中占因子V(a)活性的大部分。在正常止血过程中,血小板蛋白酶是否在凝血酶形成之前就起到激活因子V的作用还有待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e362/370322/cb4a63d530b8/jcinvest00705-0180-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验